Raquel Izumi
3PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Oct 26, 2023
Enitociclib, a Selective CDK9 Inhibitor, Induces Complete Regression of MYC+ Lymphoma by Downregulation of RNA Polymerase II Mediated Transcription.Melanie M Frigault, Arushi Mithal, Harvey Wong
|Jan 20, 2022
First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy.Jennifer R Diamond, Valentina Boni, Emerson Lim
|Jul 15, 2021
Changing for the Better: Discovery of the Highly Potent and Selective CDK9 Inhibitor VIP152 Suitable for Once Weekly Intravenous Dosing for the Treatment of Cancer.Ulrich Lücking, Dirk Kosemund, Niels Böhnke
Pageof 1
Frequent Collaborators
1 joint publications
Ulrich Lücking
1 joint publications
Valentina Boni
1 joint publications
Emerson Lim
1 joint publications
Oliver Boix
1 joint publications
Victor Moreno
1 joint publications
Melanie M Frigault
1 joint publications
Arushi Mithal
1 joint publications
Harvey Wong
1 joint publications
Beatrix Stelte-Ludwig
1 joint publications
Vinay Mandava
